IL-15 fostersage-driven regulatory T cell accrual in the face of declining IL-2 levels

Frontiers in Immunology

Volumn 4, Issue JUN, 2013, Pages

  Raynor, Jana ^a   Sholl, Allyson ^a   Plas, David R ^b   Bouillet, Philippe ^c,d   Chougnet, Claire A ^a   Hildeman, David A ^a  

^a UNIVERSITY OF CINCINNATI   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Aging; Bim; CD25; IL 15; IL 2; Treg

Indexed keywords

BIM PROTEIN; CYCLOHEXIMIDE; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 7 RECEPTOR ALPHA; PROTEIN BAK; PROTEIN BAX; TRANSCRIPTION FACTOR FOXP3;

ADOPTIVE TRANSFER; AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HOMEOSTASIS; IMMUNE RESPONSE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SPLEEN CELL;

EID: 84883773405     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00161     Document Type: Article

References (59)

1. Agius, E., Lacy, K. E., Vukmanovic-Stejic, M., Jagger, A. L., Papageorgiou, A. P., Hall, S., et al. (2009). Decreased TNF-alpha synthesis by macrophages restricts cutaneous immunosurveillance by memory CD4+ T cells during aging. J. Exp. Med. 206, 1929-1940. doi:10.1084/jem.20090896
2. Barron, L., Dooms, H., Hoyer, K. K., Kuswanto, W., Hofmann, J., O'Gorman, W. E., et al. (2010). Cutting edge: mechanisms of IL-2-dependent maintenance of functional regulatory T cells. J. Immunol. 185, 6426-6430. doi:10.4049/jimmunol.0903940
3. Bayer, A. L., Lee, J. Y., De La Barrera, A., Surh, C. D., and Malek, T. R. (2008). A function for IL-7R for CD4+CD25+Foxp3+ T regulatory cells. J. Immunol. 181, 225-234.
4. Belkaid, Y., and Oldenhove, G. (2008). Tuning microenvironments: induction of regulatory T cells by dendritic cells. Immunity 29, 362-371. doi:10.1016/j.immuni.2008.08.005
5. Bouillet, P., Purton, J. F., Godfrey, D. I., Zhang, L. C., Coultas, L., Puthalakath, H., et al. (2002). BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature 415, 922-926. doi:10.1038/415922a
6. Burchill, M. A., Yang, J., Vogtenhuber, C., Blazar, B. R., and Farrar, M. A. (2007). IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J. Immunol. 178, 280-290.
7. Castro, I., Yu, A., Dee, M. J., and Malek, T. R. (2011). The basis of distinctive IL-2-and IL-15-dependent signaling: weak CD122-dependent signaling favors CD8+ T central-memory cell survival but not T effector-memory cell development. J. Immunol. 187, 5170-5182. doi:10.4049/jimmunol.1003961
8. Chen, M., Huang, L., and Wang, J. (2007). Deficiency of Bim in dendritic cells contributes to overactivation of lymphocytes and autoimmunity. Blood 109, 4360-4367. doi:10.1182/blood-2006-11-056424
9. Chougnet, C. A., Tripathi, P., Lages, C. S., Raynor, J., Sholl, A., Fink, P., et al. (2011). A major role for Bim in regulatory T cell homeostasis. J. Immunol. 186, 156-163. doi:10.4049/jimmunol.1001505
10. Clambey, E. T., Van Dyk, L. F., Kappler, J. W., and Marrack, P. (2005). Non-malignant clonal expansions of CD8+ memory T cells in aged individuals. Immunol. Rev. 205, 170-189. doi:10.1111/j.0105-2896.2005.00265.x
11. Cornish, G. H., Sinclair, L. V., and Cantrell, D. A. (2006). Differential regulation of T-cell growth by IL-2 and IL-15. Blood 108, 600-608. doi:10.1182/blood-2005-12-4827
12. De Bruyne, E., Bos, T. J., Schuit, F., Van Valckenborgh, E., Menu, E., Thorrez, L., et al. (2010). IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanisms. Blood 115, 2430-2440. doi:10.1182/blood-2009-07-232801
13. Erlacher, M., Labi, V., Manzl, C., Bock, G., Tzankov, A., Hacker, G., et al. (2006). Puma cooperates with Bim, the rate-limiting BH3-only protein in cell death during lymphocyte development, in apoptosis induction. J. Exp. Med. 203, 2939-2951. doi:10.1084/jem.20061552
14. Finkelman, F., Morris, S., Orekhova, T., and Sehy, D. (2003). The in vivo cytokine capture assay for measurement of cytokine production in the mouse. Curr. Protoc. Immunol. Chapter 6, Unit 6.28. doi:10.1002/0471142735.im0628s54
15. Finkelman, F. D., and Morris, S. C. (1999). Development of an assay to measure in vivo cytokine production in the mouse. Int. Immunol. 11, 1811-1818. doi:10.1093/intimm/11.11.1811
16. Fontenot, J. D., Rasmussen, J. P., Gavin, M. A., and Rudensky, A. Y. (2005a). A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6, 1142-1151. doi:10.1038/ni1263
17. Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., and Rudensky, A. Y. (2005b). Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22, 329-341. doi:10.1016/j.immuni.2005.01.016
18. Garcia, G. G., and Miller, R. A. (2002). Age-dependent defects in TCR-triggered cytoskeletal rearrangement in CD4+ T cells. J. Immunol. 169, 5021-5027.
19. Golbus, J., Palella, T. D., and Richardson, B. C. (1990). Quantitative changes in T cell DNA methylation occur during differentiation and ageing. Eur. J. Immunol. 20, 1869-1872. doi:10.1002/eji.1830200836
20. Gray, D. H., Kupresanin, F., Berzins, S. P., Herold, M. J., O'Reilly, L. A., Bouillet, P., et al. (2012). The BH3-only proteins Bim and Puma cooperate to impose deletional tolerance of organ-specific antigens. Immunity 37, 451-462. doi:10.1016/j.immuni.2012.05.030
21. Hale, J. S., Boursalian, T. E., Turk, G. L., and Fink, P. J. (2006). Thymic output in aged mice. Proc. Natl. Acad. Sci. U.S.A. 103, 8447-8452. doi:10.1073/pnas.0601040103
22. Haynes, L., Eaton, S. M., Burns, E. M., Randall, T. D., and Swain, S. L. (2005). Newly generated CD4 T cells in aged animals do not exhibit age-related defects in response to antigen. J. Exp. Med. 201, 845-851. doi:10.1084/jem.20041933
23. Issa, J. P. (2003). Age-related epigenetic changes and the immune system. Clin. Immunol. 109, 103-108. doi:10.1016/S1521-6616(03)00203-1
24. Jorgensen, T. N., McKee, A., Wang, M., Kushnir, E., White, J., Refaeli, Y., et al. (2007). Bim and Bcl-2 mutually affect the expression of the other in T cells. J. Immunol. 179, 3417-3424.
25. Khan, N., Shariff, N., Cobbold, M., Bruton, R., Ainsworth, J. A., Sinclair, A. J., et al. (2002). Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J. Immunol. 169, 1984-1992.
26. Kim, J. M., Rasmussen, J. P., and Rudensky, A. Y. (2007). Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8, 191-197. doi:10.1038/ni1428
27. Kurtulus, S., Tripathi, P., Moreno-Fernandez, M. E., Sholl, A., Katz, J. D., Grimes, H. L., et al. (2011). Bcl-2 allows effector and memory CD8+ T cells to tolerate higher expression of Bim. J. Immunol. 186, 5729-5737. doi:10.4049/jimmunol.1100102
28. Lages, C. S., Suffia, I., Velilla, P. A., Huang, B., Warshaw, G., Hildeman, D. A., et al. (2008). Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation. J. Immunol. 181, 1835-1848.
29. Liao, W., Lin, J. X., and Leonard, W. J. (2013). Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity 38, 13-25. doi:10.1016/j.immuni.2013.01.004
30. Linton, P. J., and Dorshkind, K. (2004). Age-related changes in lymphocyte development and function. Nat. Immunol. 5, 133-139. doi:10.1038/ni1033
31. Maue, A. C., Yager, E. J., Swain, S. L., Woodland, D. L., Blackman, M. A., and Haynes, L. (2009). T-cell immunosenescence: lessons learned from mouse models of aging. Trends Immunol. 30, 301-305. doi:10.1016/j.it.2009.04.007
32. Miller, R. A. (2000). Effect of aging on T lymphocyte activation. Vaccine 18, 1654-1660. doi:10.1016/S0264-410X(99)00502-2
33. Miller, R. A., Garcia, G., Kirk, C. J., and Witkowski, J. M. (1997). Early activation defects in T lymphocytes from aged mice. Immunol. Rev. 160, 79-90. doi:10.1111/j.1600-065X.1997.tb01029.x
34. Miyara, M., and Sakaguchi, S. (2007). Natural regulatory T cells: mechanisms of suppression. Trends Mol. Med. 13, 108-116. doi:10.1016/j.molmed.2007.01.003
35. Murasko, D. M., Weiner, P., and Kaye, D. (1987). Decline in mitogen induced proliferation of lymphocytes with increasing age. Clin. Exp. Immunol. 70, 440-448.
36. Nishioka, T., Shimizu, J., Iida, R., Yamazaki, S., and Sakaguchi, S. (2006). CD4+CD25+Foxp3+ T cells and CD4+CD25-Foxp3+ T cells in aged mice. J. Immunol. 176, 6586-6593.
37. Onishi, Y., Fehervari, Z., Yamaguchi, T., and Sakaguchi, S. (2008). Foxp3+ natural regulatory T cells preferentially form aggregates on dendritic cells in vitro and actively inhibit their maturation. Proc. Natl. Acad. Sci. U.S.A. 105, 10113-10118. doi:10.1073/pnas.0711106105
38. Ouyang, Q., Wagner, W. M., Wikby, A., Walter, S., Aubert, G., Dodi, A. I., et al. (2003). Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old. J. Clin. Immunol. 23, 247-257. doi:10.1023/A:1024580531705
39. Paschos, K., Smith, P., Anderton, E., Middeldorp, J. M., White, R. E., and Allday, M. J. (2009). Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim. PLoS Pathog. 5, e1000492. doi:10.1371/journal.ppat.1000492
40. Richter-Larrea, J. A., Robles, E. F., Fresquet, V., Beltran, E., Rullan, A. J., Agirre, X., et al. (2010). Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma. Blood 116, 2531-2542. doi:10.1182/blood-2010-02-268003
41. Rubtsov, Y. P., Rasmussen, J. P., Chi, E. Y., Fontenot, J., Castelli, L., Ye, X., et al. (2008). Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28, 546-558. doi:10.1016/j.immuni.2008.02.017
42. Salih, D. A., and Brunet, A. (2008). FoxO transcription factors in the maintenance of cellular homeostasis during aging. Curr. Opin. Cell Biol. 20, 126-136. doi:10.1016/j.ceb.2008.02.005
43. San Jose-Eneriz, E., Agirre, X., Jimenez-Velasco, A., Cordeu, L., Martin, V., Arqueros, V., et al. (2009). Epigenetic down-regulation of BIM expression is associated with reduced optimal responses to imatinib treatment in chronic myeloid leukaemia. Eur. J. Cancer 45, 1877-1889. doi:10.1016/j.ejca.2009.04.005
44. Sempowski, G. D., Gooding, M. E., Liao, H. X., Le, P. T., and Haynes, B. F. (2002). T cell receptor excision circle assessment of thymopoiesis in aging mice. Mol. Immunol. 38, 841-848. doi:10.1016/S0161-5890(01)00122-5
45. Sharma, S., Dominguez, A. L., and Lustgarten, J. (2006). High accumulation of T regulatory cells prevents the activation of immune responses in aged animals. J. Immunol. 177, 8348-8355.
46. Stahl, M., Dijkers, P. F., Kops, G. J., Lens, S. M., Coffer, P. J., Burgering, B. M., et al. (2002). The forkhead transcription factor FoxO regulates transcription of p27Kip1 and Bim in response to IL-2. J. Immunol. 168, 5024-5031.
47. Takeuchi, O., Fisher, J., Suh, H., Harada, H., Malynn, B. A., and Korsmeyer, S. J. (2005). Essential role of BAX, BAK in B cell homeostasis and prevention of autoimmune disease. Proc. Natl. Acad. Sci. U.S.A. 102, 11272-11277. doi:10.1073/pnas.0504783102
48. Tamir, A., Eisenbraun, M. D., Garcia, G. G., and Miller, R. A. (2000). Age-dependent alterations in the assembly of signal transduction complexes at the site of T cell/APC interaction. J. Immunol. 165, 1243-1251.
49. Thoman, M. L., and Weigle, W. O. (1981). Lymphokines and aging: interleukin-2 production and activity in aged animals. J. Immunol. 127, 2102-2106.
50. reg cell development and limits their functionality in mice. J. Autoimmun. 38, 59-69. doi:10.1016/j.jaut.2011.12.008
51. regs. J. Clin. Invest. 115, 1953-1962. doi:10.1172/JCI23963
52. Vang, K. B., Yang, J., Mahmud, S. A., Burchill, M. A., Vegoe, A. L., and Farrar, M. A. (2008). IL-2, -7, and -15, but not thymic stromal lymphopoeitin, redundantly govern CD4+Foxp3+ regulatory T cell development. J. Immunol. 181, 3285-3290.
53. Waldmann, T. A. (2006). The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design. Nat. Rev. Immunol. 6, 595-601. doi:10.1038/nri1901
54. Wojciechowski, S., Tripathi, P., Bourdeau, T., Acero, L., Grimes, H. L., Katz, J. D., et al. (2007). Bim/Bcl-2 balance is critical for maintaining naive and memory T cell homeostasis. J. Exp. Med. 204, 1665-1675.
55. Wrenshall, L. E., and Platt, J. L. (1999). Regulation of T cell homeostasis by heparan sulfate-bound IL-2. J. Immunol. 163, 3793-3800.
56. Yamazaki, S., Iyoda, T., Tarbell, K., Olson, K., Velinzon, K., Inaba, K., et al. (2003). Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198, 235-247. doi:10.1084/jem.20030422
57. Yang, K., Neale, G., Green, D. R., He, W., and Chi, H. (2011). The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function. Nat. Immunol. 12, 888-897. doi:10.1038/ni.2068
58. Youle, R. J., and Strasser, A. (2008). The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 9, 47-59. doi:10.1038/nrm2308
59. Zhan, Y., Zhang, Y., Gray, D., Carrington, E. M., Bouillet, P., Ko, H. J., et al. (2011). Defects in the Bcl-2-regulated apoptotic pathway lead to preferential increase of CD25 low Foxp3+ anergic CD4+ T cells. J. Immunol. 187, 1566-1577. doi:10.4049/jimmunol.1100027